Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $274.9M | $376.9M | $384.5M | $493.8M | $553.8M | $655.5M | $741.3M | $820.7M | $940.7M | $989.8M | $1,011.4M | $1,066.5M | $1,201.7M | $1,362.2M | $1,536.6M | $1,717.8M | $1,839.1M | $2,024.3M | $2,355.7M | $2,655.3M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, ResMed Inc.'s last 12-month Gross Profit is $2,854.3M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, ResMed Inc.'s Gross Profit growth was 15.0%. The average annual Gross Profit growth rates for ResMed Inc. have been 15.8% over the past three years, 11.7% over the past five years.
Over the last year, ResMed Inc.'s Gross Profit growth was 15.0%, which is higher than industry growth of (0.1%). It indicates that ResMed Inc.'s Gross Profit growth is Good.